The 65 rating InvestorsObserver gives to Aileron Therapeutics Inc (ALRN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 75 percent of stocks in the Biotechnology industry, ALRN’s 65 overall rating means the stock scores better than 65 percent of all stocks.
ALRN has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on ALRN!